SCHEMBL9178337

SCHEMBL9178337

CC(C)COc1ccccc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.68
MAOA P21397 1/20 0.61
PTGS1 P23219 1/20 0.61
MAPT P10636 2/20 0.59
POLB P06746 1/20 0.59
HPGD P15428 1/20 0.59
XBP1 P17861 1/20 0.59
MEN1 O00255 1/20 0.54
ALOX12 P18054 1/20 0.54
KMT2A Q03164 1/20 0.54
SCN4A P35499 2/20 0.54
MTNR1A P48039 3/20 0.53
MTNR1B P49286 3/20 0.53
CYP2D6 P10635 3/20 0.53
ADRB2 P07550 1/20 0.53
ADRB1 P08588 1/20 0.53
ADRB3 P13945 1/20 0.53
KCNA3 P22001 1/20 0.50
NPC1 O15118 1/20 0.47
MTOR P42345 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL97377 1.00 LMNA (0.68) LMNAMAOAPTGS1MAPTPOLB
Ammonia Solution, Strong SCHEMBL28834669 0.98 LMNA (0.65) LMNAMAOAPTGS1MAPTPOLB
Ethylene Glycol SCHEMBL6560927 0.91 LMNA (0.64) LMNAMAOAPTGS1MAPTPOLB
Ether SCHEMBL7051516 0.89 LMNA (0.57) LMNAMAOAPTGS1MAPTPOLB
SCHEMBL10583987 0.88 LMNA (0.55) LMNAMAOAPTGS1MAPTPOLB
Propylene Glycol SCHEMBL6558972 0.88 LMNA (0.71) LMNAMAOAPTGS1MAPTPOLB
SCHEMBL123415 0.87 MAPT (0.55) LMNAMAOAPTGS1MAPTPOLB
SCHEMBL14672093 0.87 MAPT (0.57) LMNAMAOAPTGS1MAPTPOLB
SCHEMBL20385241 0.86 LMNA (0.63) LMNAMAOAPTGS1MAPTPOLB
SCHEMBL13385106 0.85 LMNA (0.68) LMNAMAOAPTGS1SCN4AMTNR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5422360-A Hydrazonoimidazolidin-4-one derivatives; treatment of diabetes and aging disorders OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1995-06-06 US disclosed
EP-0531812-A1 Maillard reaction inhibitor, process for producing it, composition containing it and the use thereof OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1993-03-17 EP disclosed